Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Jul 7, 2009

Premium

CLC Bio has released version 3.6 of its CLC Genomics Workbench desktop application and version 1.6 of its CLC Genomics Server enterprise platform. The new versions offer better support for digital gene expression analysis. In addition, CLC Genomics Workbench offers expanded chromatin immunoprecipitation sequencing analysis capabilities, as well as several other improvements.


DNAStar has launched a new version of its NGen next-generation sequence assembly software. NGen 2.0 has increased capacity for reference-guided or de novo assemblies using the company's Lasergene software. It can also be used to assemble data for RNA-seq projects run using the firm's ArrayStar gene expression software platform. It also offers a new networking capability. The company said it has used the software to assemble reference genomes up to 250 megabases in length on a desktop computer.


Eurofins MWG Operon has launched its PCReady primer design and manufacturing service in its American markets. Its American customers can now design primers 15 to 29 bases in length using the company's primer design tool and order them online for a price of $4.90 per PCReady primer, regardless of length.


Rubicon Genomics has introduced its PicoPlex single cell whole-genome amplification kit for pre-implantation genetic diagnostics and stem cell and cancer cell research, including sequencing analysis. The company claims that the kit is a more rapid, accurate, and reproducible method for amplifying single genomes than current technologies that use molecular displacement amplification. The kit amplifies total DNA a million-fold from single cells to produce five micrograms of amplified DNA in less than three hours, according to Rubicon.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.